{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-008961","form_type":"8-K","ticker":"OCEA","cik":"0001869974","company_name":"Ocean Biomedical, Inc.","filed_at":"2023-03-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:47.286354+00:00","generated_at":"2026-06-17T15:39:05.396278+00:00","sec_items":["1.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Ocean Biomedical extends $1.05M loans, raises interest to 15% and adds share issuance penalties","bullets":["Modified $1.05M Sponsor Loan maturity to May 22, 2023; interest increased from 8% to 15% compounded monthly.","SPAC Loan maturity extended to May 19, 2023; proceeds of any $15M+ capital raise to repay loans first.","Company to issue 50,000 shares to Lender immediately and 50,000 shares each 30-day anniversary thereafter until repaid.","Default penalties: Sponsor to transfer 250,000 shares per month; Company liable for 250,000 shares per month if it defaults on obligations.","Side Letter: If SPAC Loan not repaid by May 19, Company must issue 250,000 shares to Sponsor immediately."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-008961","json":"https://secwatch.observer/filing/0001493152-23-008961.json","markdown":"https://secwatch.observer/filing/0001493152-23-008961.md","text":"https://secwatch.observer/filing/0001493152-23-008961.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1869974/000149315223008961/0001493152-23-008961-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1869974/000149315223008961/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T15:39:05.396278+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"fa037887859dd55dc1eb7bd4781b8e80f8a55145","claim":"Ocean Biomedical, Inc. entered into Loan Modification Agreement with NPIC Limited valued at modified $1,050,000 loan (effective 2023-03-22).","evidence_excerpt":"On March 22, 2023 Ocean Biomedical, Inc. (f/k/a Aesther Healthcare Acquisition Corp.) (the “ Company ”) entered into a Loan Modification Agreement, dated March 22, 2023 (the “ Modification Agreement ”), by and among the Company, Aesther Healthcare Sponsor, LLC (the “ Sponsor ”), and NPIC Limited (the “ Lender ”), and a Side Letter Agreement between the Company and the Sponsor (the “ Side Letter ”), which modifies that certain Loan and Transfer Agreement, dated December 13, 2022 (the “ Original Agreement ” and, together with the Modification Agreement and Side Letter, the “ Loan Agreements ”), by and among the Company, the Sponsor, and the Lender.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1869974/000149315223008961/0001493152-23-008961-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"NPIC Limited"},{"label":"Value","value":"modified $1,050,000 loan"},{"label":"Effective","value":"2023-03-22"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}